Request Demo
Last update 10 May 2026
HSK-44459
Last update 10 May 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HSK44459 |
Target |
Action inhibitors |
Mechanism PDE4B inhibitors(Phosphodiesterase 4B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
10
Clinical Trials associated with HSK-44459NCT07503587
A Randomised, Double-blind, Placebo-controlled Parallel Group Phase III Clinical Study Evaluating the Efficacy and Safety of HSK44459 Tablets in Subjects With Progressive Pulmonary Fibrosis
NCT07519070
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis
NCT07150988
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
100 Clinical Results associated with HSK-44459
Login to view more data
100 Translational Medicine associated with HSK-44459
Login to view more data
100 Patents (Medical) associated with HSK-44459
Login to view more data
100 Deals associated with HSK-44459
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Phase 3 | - | 05 Apr 2026 | |
| Progressive pulmonary fibrosis | Phase 3 | - | 05 Apr 2026 | |
| Plaque psoriasis | Phase 2 | China | 26 Sep 2025 | |
| Dermatitis, Atopic | Phase 2 | China | 22 May 2025 | |
| Dermatitis, Atopic | Phase 2 | China | 22 May 2025 | |
| Behcet Syndrome | Phase 2 | - | 24 Mar 2025 | |
| Colitis, Ulcerative | IND Approval | China | 30 Dec 2025 | |
| Crohn Disease | IND Approval | China | 30 Dec 2025 | |
| Psoriasis | IND Approval | China | 11 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free